Skip to content

Clinical trials

Phase 1 Carcinoma, Merkel Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Merkel Cell Phase: Phase 1 Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20102
20121
20141
20163
20173
20184
20196
20206
20213
20223
20233
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated10
Recruiting6
Active, not recruiting5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fate Therapeutics3
Incyte Corporation3
AbbVie2
H. Lee Moffitt Cancer Center and Research Institute2
Memorial Sloan Kettering Cancer Center2
National Cancer Institute (NCI)2
Novartis Pharmaceuticals2
Pfizer2
TuHURA Biosciences, Inc.2
University of Southern California2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Merkel Cell40
Melanoma22
Carcinoma, Non-Small-Cell Lung17
Carcinoma, Renal Cell16
Small Cell Lung Carcinoma16
Carcinoma, Hepatocellular12
Carcinoma, Transitional Cell12
Stomach Neoplasms11
Uterine Cervical Neoplasms11
Cutaneous Squamous Cell Carcinoma10

Trials

Showing 51 to 40 of 40. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.